Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease

Lancet

Volumn 348, Issue 9020, 1996, Pages 90-93

  Saunders, A M ^a   Hulette, C ^a   Welsh Bohmer, K A ^a   Schmechel, D E ^a   Crain, B ^a   Burke, J R ^a   Alberts, M J ^a   Strittmatter, W J ^a   Breitner, J C S ^a   Rosenberg, C ^a   Scott, S V ^a   Gaskell Jr , P C ^a   Pericak Vance, M A ^a   Roses, A D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN TISSUE; DIAGNOSTIC ACCURACY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROPATHOLOGY; PRIORITY JOURNAL;

EID: 15844393893     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)01251-2     Document Type: Article

References (33)

1. 1 Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977-81.
2. 2 Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epislon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72.
3. 3 Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-23.
4. 4 Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ 1994; 309: 636-68.
5. 5 Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994; 36: 889-95.
6. 6 Schachter F, Faure DL, Guenot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994; 6: 29-32.
7. 7 Saunders AM, Schmader K, Breitner JC, et al. Apolipoprotein E epislon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993; 342: 710-11.
8. 8 Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994; 7: 180-84.
9. 9 Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994; 53: 429-37.
10. 10 Rebeck GW, Perls TT, West HL, et al. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994; 44: 1513-16.
11. 11 Roses AD, Strittmatter WJ, Pericak VM, Corder EH, Saunders AM, Schmechel DE. Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet 1994; 343: 1564-65.
12. 12 Ueki A, Kawano M, Namba Y, Kawakami M, Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett 1993; 163: 166-68.
13. 13 Yoshizawa T, Yamakawa KK, Komatsuzaki Y, et al. Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 1994; 36: 656-59.
14. 14 Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995 37: 118-20.
15. 15 Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995; 37: 254-59.
16. 16 Osuntokun BO, Sahota A, Ogunniyi AO, et al. Lack of an association between apolipoprotein E epsilon 4 and Alziemer's disease in elderly Nigerians. Ann Neurol 1995; 38: 463-65.
17. 17 Roses AD. Apolipoprotein E genotyping in differential diagnosis, not prediction of Alzheimer's disease. Ann Neurol 1995; 38: 6-14.
18. 18 Bird TD. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view. Ann Neurol 1995; 38: 2-3.
19. 19 Farrer LA, Brin MF, Elsas L, et al. Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. JAMA 1995; 274: 1627-29.
20. 20 Relkin NR. Consensus statement: apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996; 347: 1091-09.
21. 21 Poirier J, Delisle MC, Quirion R, et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 1995; 92: 12260-64.
22. 22 Elston RC, Johnson WD. Essential of biostatistics, 2nd ed. Philadelphia: FA Davis, 1994.
23. 23 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer' disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
24. 24 Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Working Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 1988; 38: 359-64.
25. 25 Gearing M, Mirra SS, Hedreen JC, Sumi SM, Hansen LA. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): X neurological confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 1995; 45: 461-66.
26. 26 Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250-60.
27. 27 Mirra SS, Heyman A, McKeel D, et al. CERAD: II standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-81.
28. 28 Hixson JE, Vernier DT. Restriction isotyping of human APOE by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-48.
29. 29 Roses AD, Pericak-Vance MA. Alzheimer's disease and other dementias. Emery & Rimoins principles and practice of medical genetics. New York: Churchill Livingstone, 1995.
30. 30 Breitner JCS. APOE genotyping and Alzheimer's disease. Lancet 1996; 347: 1184-85.
31. 31 van Duijn CM, de Knijff P, Wehnert A, et al. Apolipoprotein E epsilon 2 allele associated with increased risk of early-onset Alzheimer's disease and reduced survival. Ann Neurol 1995; 37: 605-10.
32. 32 Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 1995; 333: 1242-47.
33. 33 Seshadri S, Drachman DA, Lippa CF. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease: what physicians know, and what they should know. Arch Neurol 1995; 52: 1074-79.